Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double-blind placebo-controlled trial (Q33585572)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double-blind placebo-controlled trial |
scientific article |
Statements
1 reference
Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double-blind placebo-controlled trial (English)
1 reference
Jo Satoh
1 reference
Soroku Yagihashi
1 reference
Masayuki Baba
1 reference
Makoto Suzuki
1 reference
Akio Arakawa
1 reference
Tamotsu Yoshiyama
1 reference
1 November 2011
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference